XFOR (X4 Pharmaceuticals, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
X4 Pharmaceuticals, Inc. Common Stock (XFOR) is a publicly traded Healthcare sector company. As of May 21, 2026, XFOR trades at $3.82 with a market cap of $347.10M and a P/E ratio of -19.95. XFOR moved +4.12% today. Year to date, XFOR is -1.82%; over the trailing twelve months it is +39.11%. Its 52-week range spans $1.35 to $26.83. Analyst consensus is buy with an average price target of $12.00. Rallies surfaces XFOR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns XFOR stock?
Hedge funds tracked by Rallies that own XFOR include Orbimed Advisors. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for X4 Pharmaceuticals, Inc. Common Stock.
XFOR Key Metrics
Key financial metrics for XFOR
Metric
Value
Price
$3.82
Market Cap
$347.10M
P/E Ratio
-19.95
EPS
$-0.19
Dividend Yield
0.00%
52-Week High
$26.83
52-Week Low
$1.35
Volume
25
Avg Volume
0
Revenue (TTM)
$2.56M
Net Income
$-37.45M
Gross Margin
68.83%
Top Hedge Funds Holding XFOR
Orbimed Advisors holds 6.78M shares of XFOR, changed -5.00% as of Mar 31, 2025.
Hedge funds tracked by Rallies that own XFOR include Orbimed Advisors. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for X4 Pharmaceuticals, Inc. Common Stock.
Does Rallies show 13F holders for XFOR?
Yes. Rallies tracks hedge fund and 13F ownership data for XFOR, including fund names, share counts, latest tracked quarter, and position changes when available.
Is XFOR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for XFOR. It does not provide personalized investment advice.
